BristolMyers Squibb

Vice President & Head of Neuroscience Portfolio Strategy & Alliances

BristolMyers Squibb • $326K — $395K *
Princeton, NJ 08540In-Person
Pharmaceuticals & Biotech
11 - 15 years of experience
Today
Be an Early Applicant
Job Overview by Ladders

Qualifications

  • 15+ years of experience in the biopharmaceutical industry with a focus on neuroscience
  • Proven track record in strategic portfolio management and drug development
  • Strong scientific background in neuropsychiatry, neurology, or related fields
  • Experience leading cross-functional teams in a matrixed environment
  • Exceptional stakeholder management and communication skills
  • Demonstrated ability to align and influence senior leadership

Responsibilities

  • Lead the strategy development for neuroscience portfolio across various disease areas
  • Integrate asset strategies into a cohesive portfolio ambition
  • Conduct cross-portfolio assessments and scenario planning to inform asset decisions
  • Develop frameworks for prioritization based on scientific and patient needs
  • Collaborate with disease area heads and teams for effective resource allocation
  • Oversee strategic planning for neuroscience congress engagements
  • Define and manage external partnerships to enhance portfolio strength

Benefits

  • Comprehensive health insurance plans
  • Retirement savings options with company matching
  • Generous paid time off and holidays
  • Opportunities for professional development and training
  • Wellness programs and resources for work-life balance
  • Flexible work arrangements promoting a healthy work environment
Full Job Description
Position: Vice President & Head of Neuroscience Portfolio Strategy & Alliances
Location: Princeton Pike, NJ
Reporting to: Senior Vice President, Head of Global Medical Neuroscience

Position Summary

Bristol Myers Squibb is seeking an enterprise-minded leader to serve as Vice President & Head of Neuroscience Portfolio Strategy & Alliances.

This leader will be responsible for shaping and integrating the overarching Neuroscience portfolio strategy across neuropsychiatry and neurology, including dementia and other neurodegenerative diseases. The role will translate individual disease-area and asset strategies into clear portfolio-level choices regarding asset and indication prioritization, investment, resource allocation, sequencing, external partnerships, and enterprise positioning.

The leader will also lead the strategic orchestration of BMS's overarching Neuroscience and Brain Health external narrative, enterprise neuroscience congress strategy, strategic alliances, SPARC, and relevant public-private partnerships. Working across Medical, Research and Development, Commercial, Corporate Affairs, Investor Relations, Business Development, Alliance Management, and other enterprise functions, this leader will ensure that BMS presents a coherent neuroscience ambition and focuses its resources and external engagement on the opportunities with the greatest potential impact for patients.

This is a highly visible, matrixed leadership role requiring scientific credibility, portfolio judgment, business acumen, and the ability to align senior leaders around consequential choices.

Key Responsibilities

Integrated Neuroscience Portfolio Strategy and Prioritization
  • Lead the development and ongoing evolution of the integrated Neuroscience portfolio strategy across neuropsychiatry, dementia, and other neurodegenerative diseases, grounded in scientific opportunity, unmet patient need, clinical practice, and the external treatment landscape.
  • Integrate disease-area and asset strategies into a cohesive Neuroscience portfolio ambition, identifying strategic priorities, interdependencies, portfolio gaps, evidence needs, and opportunities for differentiation.
  • Bring a distinct Medical and scientific perspective to cross-portfolio assessments, including the patient journey, evolving standards of care, clinical meaningfulness, evidence requirements, external stakeholder needs, and the feasibility of changing medical practice.
  • Lead cross-portfolio assessments and scenario planning to inform choices among assets, indications, evidence-generation opportunities, external collaborations, and investments.
  • Develop transparent prioritization frameworks that incorporate unmet patient need, strength of scientific rationale, clinical potential, probability of success, competitive differentiation, evidence requirements, feasibility, strategic fit, and enterprise value.
  • Partner with Disease Area Heads, Research, Development, Commercial, Finance, and enterprise portfolio teams to formulate recommendations regarding asset and indication prioritization, resource allocation, portfolio sequencing, acceleration, expansion, partnering, or deprioritization.
  • Ensure that portfolio recommendations reflect both internal asset potential and the external realities of clinical practice, patient needs, scientific advancement, and the evolving competitive environment.
  • Reassess portfolio priorities as scientific evidence, development milestones, clinical practice, competitive conditions, external opportunities, and enterprise priorities evolve.
  • Provide the Neuroscience Leadership Team and relevant governance bodies with clear, decision-ready recommendations, including the scientific and medical rationale, patient implications, strategic trade-offs, risks, and resource requirements.


Neuroscience and Brain Health Scientific Narrative and External Medical Strategy
  • Lead the development of the overarching Neuroscience and Brain Health scientific narrative, connecting BMS's disease areas, assets, scientific platforms, evidence, partnerships, and patient priorities into a coherent expression of the company's scientific ambition.
  • Ensure that the narrative is scientifically rigorous, clinically relevant, patient-centered, and appropriately grounded in the maturity and evidence supporting the portfolio.
  • Define the core scientific and medical themes that should guide BMS Neuroscience engagement with healthcare professionals, researchers, scientific societies, patient and advocacy communities, academic institutions, consortia, and other health-system stakeholders.
  • Partner with Disease Area Heads and asset teams to ensure that individual disease and asset narratives contribute to-and remain consistent with-the broader Neuroscience and Brain Health scientific strategy.
  • Identify scientific, evidence, and external-understanding gaps that could limit differentiation of the Neuroscience portfolio and work with the appropriate teams to address them.
  • Translate the scientific narrative into clear strategic guidance for scientific exchange, evidence generation, publications, medical education, congress engagement, partnerships, and other external Medical activities.
  • Partner with Corporate Affairs to ensure that the scientific and medical foundations of the portfolio are accurately reflected in the broader enterprise Neuroscience narrative and external communications.
  • Provide scientific and medical context to Investor Relations, Commercial, Government Affairs, and other functions while respecting their ownership of investor communications, brand positioning, policy engagement, communications channels, and functional execution.
  • Ensure that insights generated through external scientific and patient engagement inform the ongoing evolution of the Neuroscience portfolio strategy and scientific narrative.


Enterprise Neuroscience Congress Strategy and Oversight
  • Own the overarching enterprise congress strategy for Neuroscience across priority global, US, and regional scientific meetings.
  • Establish the Neuroscience congress portfolio, including congress tiering, investment priorities, enterprise objectives, target audiences, expected outcomes, and leadership engagement.
  • Convene and align Medical, Development, Commercial, Corporate Affairs, Investor Relations, Congress Excellence, and other relevant teams around an integrated strategy for major neuroscience congresses.
  • Ensure that scientific disclosures, medical education, external engagement, executive participation, media activity, investor communications, competitive intelligence, and partnership discussions collectively advance the portfolio strategy and Neuroscience narrative.
  • Provide strategic oversight across congresses to prevent fragmented asset-level execution and ensure appropriate balance across current brands, pipeline assets, disease areas, and longer-term scientific ambition.
  • Establish clear pre-congress objectives and post-congress reviews, ensuring that scientific, competitive, stakeholder, and partnering insights are translated into portfolio actions.
  • Represent BMS Neuroscience in select high-level scientific forums, leadership meetings, and external engagements, as appropriate.


Strategic Alliances and External Engagement
  • Define the Neuroscience alliance and external-engagement strategy based on portfolio priorities, capability gaps, scientific opportunities, and patient needs.
  • Identify where alliances with academia, biotechnology companies, industry partners, foundations, advocacy organizations, consortia, and other external stakeholders could accelerate or strengthen the portfolio.
  • Serve as the Neuroscience strategic sponsor or senior representative for selected high-priority alliances and collaborations.
  • Partner with Business Development, Alliance Management, Research and Development, Legal, Finance, and other functions to evaluate opportunities and establish appropriate strategic objectives, governance, performance measures, and decision pathways.
  • Ensure that alliance activity is connected to defined portfolio needs rather than pursued as a collection of independent external relationships.
  • Conduct regular strategic reviews of priority alliances to assess scientific progress, portfolio relevance, value realization, risks, and the need to expand, modify, or conclude the collaboration.
  • Ensure that knowledge and capabilities generated through alliances are integrated into Neuroscience strategy and internal decision-making.


SPARC Leadership and Strategic Oversight
  • Provide strategic oversight of SPARC within Neuroscience, ensuring that its priorities and activities are aligned with the broader Neuroscience portfolio and Brain Health ambition.
  • Define the role SPARC should play in advancing scientific collaboration, stakeholder engagement, patient impact, and solutions to system-level barriers in neuroscience.
  • Establish clear objectives, governance, measures of impact, and connections between SPARC activities and BMS's disease-area and portfolio strategies.
  • Ensure that SPARC generates actionable insights, relationships, and initiatives that can inform portfolio strategy, evidence generation, external engagement, and public-private collaboration.
  • Represent SPARC internally and externally and ensure appropriate engagement from senior BMS leaders and external partners.


Public-Private and Precompetitive Partnerships
  • Identify and shape public-private and precompetitive partnerships capable of advancing the broader neuroscience ecosystem in areas such as biomarkers, diagnosis, clinical-trial infrastructure, data standards, disease understanding, patient identification, and research methods.
  • Evaluate potential partnerships based on their alignment with portfolio priorities, scientific value, patient impact, feasibility, and the distinctive contribution BMS can make.
  • Serve as a senior BMS representative in selected national and international partnerships, consortia, and multilateral initiatives.
  • Partner with relevant enterprise functions to establish fit-for-purpose governance, funding principles, performance measures, and decision pathways.
  • Ensure that participation in public-private partnerships produces clear scientific, strategic, ecosystem, or patient value and that resulting insights are incorporated into internal strategy.


Strategic Intelligence and Portfolio Insights
  • Integrate scientific, clinical, competitive, market, stakeholder, policy, and partnership intelligence into Neuroscience portfolio decision-making.
  • Identify emerging scientific advances, external assets, technologies, policy developments, and changes in standards of care that could create opportunities or risks for the portfolio.
  • Develop concise executive perspectives on the implications of external developments for BMS's portfolio, investment priorities, partnerships, and external positioning.
  • Ensure that insights from congresses, alliances, SPARC, scientific leaders, patient organizations, and other external stakeholders are systematically captured and translated into action.


Enterprise Leadership and Organizational Impact
  • Serve as a senior strategic partner to the SVP, Head of Global Medical Neuroscience, the Neuroscience Leadership Team, and enterprise leaders involved in Neuroscience.
  • Chair or lead appropriate cross-functional portfolio, alliance, external-strategy, and congress governance forums.
  • Create clarity regarding decisions, recommendations, ownership, execution responsibilities, and escalation pathways across the matrix.
  • Lead and develop a high-performing team with capabilities spanning portfolio strategy, strategic alliances, external engagement, and enterprise integration.
  • Foster a culture of scientific rigor, transparency, constructive challenge, disciplined prioritization, and accountability for outcomes.
  • Represent the broader interests of the Neuroscience portfolio, balancing individual asset and functional priorities with what will generate the greatest impact for patients and BMS.


Decision Scope

The Leader is accountable for:
  • Developing the integrated Neuroscience portfolio strategy.
  • Leading portfolio-level prioritization and resource-allocation recommendations.
  • Establishing the strategic architecture of the Neuroscience and Brain Health narrative.
  • Defining the enterprise Neuroscience congress strategy.
  • Establishing the Neuroscience alliance and external-engagement strategy.
  • Providing strategic oversight of SPARC and neuroscience public-private partnerships.
  • Convening the appropriate functions and ensuring that portfolio decisions translate into coordinated execution.


Formal investment,

About BristolMyers Squibb

BristolMyers Squibb Careers

Join the vibrant team at BristolMyers Squibb, a leader in global biopharmaceutical innovation, where your career growth is as important as the life-changing solutions we develop. At BristolMyers Squibb, we are committed to fostering a diverse and inclusive workplace that encourages professional growth and development. Work You’ll Do Embark on a career with BristolMyers Squibb and be part of a company that’s dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. With us, you’ll contribute to a culture that embraces scientific innovation, responsible leadership, and community outreach. Explore job opportunities in various fields from research to marketing, and join a team that values leadership and diversity. Our commitment to career growth means we support your journey with extensive training programs, leadership development opportunities, and a global, diverse network of professionals. Innovative Work At BristolMyers Squibb, innovation is at the core of everything we do. From pioneering research in oncology to breakthroughs in immunology, our professionals have the opportunity to make significant contributions to the field and impact lives globally. Our collaborative environment encourages team members to challenge the status quo and bring forward ideas that pave the way for groundbreaking solutions. Be Part of a Great Team Working at BristolMyers Squibb means being part of a team that supports your aspirations and shares your values. Our culture thrives on teamwork, respect, and diversity, creating a workplace where everyone can achieve their potential. Enjoy the benefits of being part of a company that values work-life balance, provides competitive benefits, and fosters an environment where skills and leadership are developed through hands-on experience and comprehensive mentorship programs. Future-Proof Your Career With a multitude of job opportunities ranging from internships to full-time positions, BristolMyers Squibb is not just hiring; we’re building futures. We equip our employees with the tools needed for success, including advanced training in diverse skill sets, leadership programs, and opportunities for professional networking and growth. Stay Connected Join Our Team Search open positions that match your skills and interests. We are looking for passionate, curious, and innovative team players who are ready to make a difference. Explore our career portal for all current job listings and be sure to submit your resume. Keep Up to Date Stay informed with the latest company news, career tips, and industry insights from BristolMyers Squibb. Our careers blog is a resource for potential and current employees looking to maximize their career potential. Job Alert Emails Customize your subscription to receive job alerts and insider information tailored to your preferences. Discover the exciting and rewarding career opportunities that await at BristolMyers Squibb. At BristolMyers Squibb, your career is just the beginning – it’s a pathway to personal and professional fulfillment. Join us and make a global impact.
Learn more about BristolMyers Squibb
Size
32,200 employees
Market Cap
$156.3 billion
Industry
Pharmaceuticals & Biotech
Net Income
-$9 billion
Founded
1887
5 Year Trend
+19%
Revenue
$42.5 billion
NASDAQ
BMY
* Ladders Estimates

Similar Jobs

Ad banner background

Get Ready For Your
Next Interview

More Jobs at BristolMyers Squibb

More Pharmaceuticals & Biotech Jobs

Find similar Vice President & Head of Neuroscience Portfolio Strategy & Alliances jobs:

NationwidePrinceton, NJ